Drugs in Psychiatric Disorders — MCQs

Drugs in Psychiatric Disorders Indian Medical PG Practice Questions and MCQs

Question 341: What is the drug of choice for treating delirium tremens?

A. Phenytoin
B. Morphine
C. Lorazepam (Correct Answer)
D. Diazepam

Explanation: ***Lorazepam*** - **Benzodiazepines** are the first-line treatment for **delirium tremens** due to their effectiveness in reducing central nervous system hyperexcitability through GABA-A receptor agonism. - **Lorazepam** is often preferred, especially in patients with liver impairment (common in chronic alcoholics), because it is metabolized by **glucuronidation** rather than hepatic oxidation, making it safer in hepatic dysfunction. - It has an **intermediate half-life (10-20 hours)** with **no active metabolites**, providing predictable pharmacokinetics and easier dose titration. - Can be administered via multiple routes (IV, IM, oral), making it versatile in acute settings. *Diazepam* - Also a **first-line benzodiazepine** for alcohol withdrawal and delirium tremens, particularly effective in patients with normal liver function. - Has a **long half-life (20-100 hours)** with **active metabolites** (desmethyldiazepam), which can accumulate in patients with hepatic impairment, leading to prolonged sedation. - Metabolized by hepatic **oxidation** (CYP450), making it less ideal in liver disease. - The longer duration of action can be advantageous for tapering protocols but may cause excessive sedation in vulnerable patients. *Phenytoin* - **Phenytoin** is an **anticonvulsant** that is **not effective** for treating delirium tremens or alcohol withdrawal seizures as monotherapy. - It does not address the primary pathophysiology of alcohol withdrawal, which involves GABAergic and glutamatergic system imbalance. - May be used as **adjunctive therapy** in patients with concurrent seizure disorders, but benzodiazepines remain the mainstay. *Morphine* - **Morphine** is an **opioid analgesic** with **no role** in the treatment of delirium tremens. - Use of opioids could **worsen respiratory depression**, particularly dangerous in agitated patients with potential for aspiration. - Does not address the neurochemical basis of alcohol withdrawal and may complicate management.

Question 342: Which drug is most commonly used worldwide in maintenance treatment for opioid dependence?

A. Disulfiram
B. Methadone (Correct Answer)
C. Naltrexone
D. Imipramine

Explanation: ***Methadone (Correct Answer)***- It is a **long-acting opioid agonist** that helps reduce cravings and withdrawal symptoms associated with opioid dependence, making it highly effective for maintenance treatment [2].- Its widespread availability and established efficacy in reducing illicit opioid use, crime, and disease transmission contribute to its global prevalence [1].- Methadone acts on **μ-opioid receptors** [2] and has a long half-life (24-36 hours), allowing once-daily dosing in maintenance therapy.*Disulfiram (Incorrect)*- This drug is primarily used in the management of **alcohol dependence** by causing unpleasant reactions when alcohol is consumed (inhibits aldehyde dehydrogenase) [3].- It has no role in the treatment of opioid dependence, as its mechanism of action is unrelated to opioid receptors.*Naltrexone (Incorrect)*- While used for opioid dependence, **naltrexone** is an **opioid antagonist** that blocks the effects of opioids [4].- Its use requires complete detoxification from opioids before initiation to avoid precipitated withdrawal, which can be a barrier to its common use in maintenance compared to methadone [1].- Less commonly used globally compared to methadone for maintenance treatment.*Imipramine (Incorrect)*- **Imipramine** is a **tricyclic antidepressant** primarily used to treat depression and some anxiety disorders.- It does not have any direct pharmacological action on opioid receptors and is not used in the treatment of opioid dependence.

Question 343: Myocarditis is a side effect of which drug(s)?

A. clozapine (Correct Answer)
B. aripiprazole
C. olanzapine
D. chlorpromazine

Explanation: ***Clozapine*** - **Clozapine** is an atypical antipsychotic known to cause several serious side effects, including **myocarditis**, particularly during the initial weeks of treatment. - Patients on clozapine must be monitored for symptoms of myocarditis, such as **tachycardia**, **fever**, chest pain, and fatigue. *Aripiprazole* - **Aripiprazole** is generally considered to have a favorable cardiovascular safety profile compared to other antipsychotics. - While it can cause some cardiovascular side effects like **orthostatic hypotension**, **myocarditis** is not a commonly associated side effect. *Olanzapine* - **Olanzapine** is associated with metabolic side effects such as weight gain, dyslipidemia, and hyperglycemia. - Although it can rarely cause other cardiovascular issues like **QT prolongation**, **myocarditis** is not a characteristic adverse effect. *Chlorpromazine* - **Chlorpromazine** is a first-generation antipsychotic often linked to **QT prolongation** and **orthostatic hypotension**. - While it can have cardiovascular effects, **myocarditis** is not typically listed as one of its prominent or common adverse reactions.

Question 344: Which of the following antipsychotics is a partial D2 agonist?

A. Clozapine
B. Quetiapine
C. Ziprasidone
D. Aripiprazole (Correct Answer)

Explanation: Aripiprazole - Aripiprazole is a D2 partial agonist [1][3], meaning it acts as an agonist in areas with low dopamine and an antagonist in areas with high dopamine [3]. - This unique mechanism helps to stabilize dopamine activity, leading to fewer extrapyramidal symptoms and hyperprolactinemia compared to typical antipsychotics. Clozapine - Clozapine is a D2 antagonist with a high affinity for D4 receptors and potent antagonism of 5-HT2A receptors; it is known for its efficacy in treatment-resistant schizophrenia [2]. - It carries a risk of severe side effects such as agranulocytosis [2] and myocarditis, requiring regular blood monitoring. Quetiapine - Quetiapine is primarily a D2 antagonist with significant antagonism at histamine H1 and alpha-1 adrenergic receptors, contributing to its sedative and orthostatic hypotensive effects. - It is known for its relatively low risk of extrapyramidal symptoms due to its rapid dissociation from D2 receptors. Ziprasidone - Ziprasidone is a D2 antagonist and a serotonin 5-HT1A agonist and 5-HT2C antagonist, contributing to its antidepressant and anti-anxiety effects. - It is associated with a risk of QTc prolongation, which necessitates cardiac monitoring in susceptible patients.

Question 345: Which of the following drugs is not useful in the rehabilitation of alcoholic patients?

A. Acamprosate
B. Rimonabant (Correct Answer)
C. Naltrexone
D. Varenicline

Explanation: Rimonabant - Rimonabant is an inverse agonist of the cannabinoid CB1 receptor that was used as an anti-obesity drug. [1] - It was withdrawn from the market due to significant psychiatric side effects, including depression and suicidal ideation. [1] - Rimonabant has absolutely no role in alcohol rehabilitation and is no longer available for clinical use. Acamprosate - Acamprosate is commonly used in alcohol rehabilitation to reduce alcohol cravings and promote abstinence in detoxified alcohol-dependent individuals. [2] - It is thought to act by restoring the balance between excitation and inhibition in the brain, particularly by modulating glutamate and GABA neurotransmission. - It is FDA-approved for maintenance of alcohol abstinence. Naltrexone - Naltrexone is an opioid receptor antagonist used to reduce alcohol craving and relapse by blocking the pleasurable effects of alcohol. [2], [3] - It is available in both oral and intramuscular long-acting injectable forms and is FDA-approved for alcohol use disorder. [3] - It can also be used for opioid use disorder. [3] Varenicline - Varenicline is a partial agonist of the nicotinic acetylcholine receptor and is primarily FDA-approved for smoking cessation. - Some research has explored its potential for reducing alcohol consumption due to its effects on reward pathways, though it is not FDA-approved for alcohol dependence. - Unlike rimonabant (which is withdrawn and has no role), varenicline has some supporting evidence in alcohol treatment, though it remains off-label use.

Question 346: Which is the mood stabilizer with a narrow therapeutic index?

A. lithium (Correct Answer)
B. valproate
C. lamotrigine
D. carbamazepine

Explanation: Correct Option: Lithium - Lithium has a narrow therapeutic index, meaning there is a small difference between therapeutic and toxic doses (therapeutic range: 0.6-1.2 mEq/L; toxic level: >1.5 mEq/L) [1] - This narrow therapeutic window necessitates frequent monitoring of serum lithium levels and careful dosage adjustments to prevent toxicity while maintaining efficacy in mood stabilization [2] - Common signs of lithium toxicity include tremor, confusion, ataxia, and in severe cases, seizures and renal failure Incorrect Option: Valproate - While valproate is an effective mood stabilizer, its therapeutic index is wider compared to lithium, making it generally safer with less stringent monitoring requirements for toxicity [4] - It's associated with adverse effects like hepatotoxicity and pancreatitis, but acute toxicity from minor dose variations is less common than with lithium Incorrect Option: Carbamazepine - Carbamazepine is an anticonvulsant and mood stabilizer with a wider therapeutic index than lithium, though it requires monitoring for drug interactions and hematologic effects (agranulocytosis, aplastic anemia) [3] - Common side effects include dizziness, ataxia, and hyponatremia, but the risk of severe toxicity from minor dose changes is significantly lower than with lithium [3] Incorrect Option: Lamotrigine - Lamotrigine is a mood stabilizer used for bipolar disorder with a relatively wide therapeutic index, especially when compared to lithium - The most concerning side effect is Stevens-Johnson syndrome, a rare but serious skin rash, which risk is increased by rapid dose escalation; requires slow titration

Question 347: What is the primary use of Naltrexone in the context of opioid dependence?

A. Prevent relapse (Correct Answer)
B. Prevent respiratory depression
C. Treatment of opioid overdose
D. Treat withdrawal symptoms

Explanation: ***Prevent relapse*** - **Naltrexone** is an **opioid antagonist** that blocks opioid receptors, thereby preventing the euphoric and other intoxicating effects of opioids. - This action helps to reduce cravings and deter opioid use, making it a primary medication for **relapse prevention** in individuals with opioid dependence. *Prevent respiratory depression* - Preventing respiratory depression is not the primary use of naltrexone; opioid antagonists like **naloxone** are used to reverse **opioid-induced respiratory depression** in overdose situations. - Naltrexone is used for longer-term management and does not have a direct role in acute respiratory support. *Treatment of opioid overdose* - While both are opioid antagonists, **naloxone** is the drug of choice for immediate **opioid overdose reversal** due to its rapid onset and shorter duration of action. - Naltrexone has a slower onset and longer duration, making it unsuitable for acute overdose treatment. *Treat withdrawal symptoms* - **Naltrexone** is generally *not* used to treat acute opioid withdrawal symptoms because it can precipitate or worsen withdrawal by blocking opioid receptors. - Withdrawal symptoms are typically managed with opioid agonists like **buprenorphine** or other symptomatic treatments.

Question 348: Which of the following is not an antidepressant?

A. Fluoxetine
B. Trazodone
C. Pimozide (Correct Answer)
D. Amitriptyline

Explanation: ***Pimozide*** - **Pimozide** is a **first-generation antipsychotic** medication primarily used to treat **Tourette's syndrome** and chronic severe tics, not depression [1], [2]. - Its mechanism involves blocking **dopamine D2 receptors**, differentiating it from typical antidepressant actions. *Amitriptyline* - **Amitriptyline** is a **tricyclic antidepressant (TCA)** commonly used to treat depression, anxiety, and neuropathic pain [2]. - Its antidepressant effect is due to the **inhibition of serotonin and norepinephrine reuptake** [2]. *Fluoxetine* - **Fluoxetine** is a widely prescribed **selective serotonin reuptake inhibitor (SSRI)**, making it a common antidepressant [2]. - It specifically **blocks the reuptake of serotonin**, leading to increased serotonin levels in the synaptic cleft [2]. *Trazodone* - **Trazodone** is an **antidepressant** with significant sedative properties, often used for depression associated with insomnia. - It acts as a **serotonin antagonist and reuptake inhibitor (SARI)**, with effects on 5-HT2A receptors and serotonin reuptake.

Question 349: Which of the following medications is most commonly associated with causing Neuroleptic Malignant Syndrome (NMS)?

A. Metoclopramide
B. Phenothiazines
C. Haloperidol (Correct Answer)
D. Clozapine

Explanation: ***Haloperidol*** - **Haloperidol** is a potent **first-generation (typical) antipsychotic** (butyrophenone class) that strongly blocks **dopamine D2 receptors**. - This potent D2 antagonism is the primary mechanism underlying the development of **Neuroleptic Malignant Syndrome (NMS)**. - The risk of NMS is **highest** with high-potency typical antipsychotics like haloperidol, especially when initiated at **high doses** or with **rapid dose escalation**. - Haloperidol is the **most commonly cited** individual agent associated with NMS in medical literature. *Phenothiazines* - **Phenothiazines** (e.g., chlorpromazine, fluphenazine) are a class of **first-generation antipsychotics** that also cause NMS due to **dopamine D2 receptor blockade**. - While phenothiazines as a class are associated with NMS, **haloperidol** (a butyrophenone) is considered the **prototypical** and most commonly cited individual drug for NMS. - High-potency phenothiazines (like fluphenazine) carry higher NMS risk than low-potency ones (like chlorpromazine). *Metoclopramide* - Metoclopramide is primarily an **antiemetic** and **prokinetic agent** that has **dopamine-blocking** properties (D2 antagonist). - It has been **rarely** associated with NMS or NMS-like reactions, but this is far less common compared to potent antipsychotics. - Its primary use is for gastrointestinal disorders, not psychiatric conditions. *Clozapine* - **Clozapine** is an **atypical (second-generation) antipsychotic** with relatively **weak D2 receptor affinity** and stronger effects on serotonin receptors. - It has the **lowest risk** of causing NMS among all antipsychotics due to its unique receptor binding profile. - Clozapine is actually sometimes used as an alternative in patients who have experienced NMS with typical antipsychotics.

Question 350: Which drug is the most useful in treating an episode of antipsychotic-induced acute dystonia?

A. Procyclidine
B. Benztropine (Correct Answer)
C. Biperiden
D. Trihexyphenidyl

Explanation: ***Benztropine*** - **Benztropine** is an anticholinergic medication that is the **conventional first-line treatment** for acute dystonic reactions caused by antipsychotics. - It works by blocking muscarinic acetylcholine receptors, thereby restoring the balance between **dopamine** and **acetylcholine** in the basal ganglia. - Can be administered **IV or IM**, providing rapid relief within 15-30 minutes. - Most commonly recommended in standard pharmacology references for Indian medical examinations. *Biperiden* - **Biperiden** is also an effective anticholinergic used for acute dystonia and can be given **IV or IM**. - Has a very rapid onset when given IV (2-5 minutes), making it equally effective for acute episodes. - While both biperiden and benztropine are acceptable first-line agents, **benztropine** is more conventionally cited in standard teaching. *Procyclidine* - **Procyclidine** is another anticholinergic drug used to treat extrapyramidal side effects, including dystonia. - Primarily available as **oral formulation**, making it less suitable for acute emergencies requiring immediate intervention. - More appropriate for maintenance therapy or less severe extrapyramidal symptoms. *Trihexyphenidyl* - **Trihexyphenidyl** is an anticholinergic medication used for drug-induced parkinsonism and dystonia. - Available only in **oral form**, making it unsuitable for acute dystonic crises requiring rapid reversal. - Better suited for chronic management rather than acute emergency treatment.

Practice by Chapter

Antipsychotics: Typical and Atypical

Practice Questions

Antidepressants: SSRIs and SNRIs

Practice Questions

Tricyclic Antidepressants

Practice Questions

MAO Inhibitors

Practice Questions

Mood Stabilizers

Practice Questions

Anxiolytics

Practice Questions

Drugs for ADHD

Practice Questions

Drugs for Sleep Disorders

Practice Questions

Drugs for Dementia

Practice Questions

Drug-Induced Psychiatric Symptoms

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free